Navigation Links
Ibuprofen and Vitamins C and E Could Halt Alzheimer's

A new study has suggested that patients who are at a high risk for developing Alzheimer's disease would benefit from taking a combination of vitamins E and C// plus ibuprofen. This therapy appears to be of maximum benefit in people who have a mutated gene for apolipoprotein, APOE-4, which is a high-risk condition predisposing them to Alzheimer's disease.

Researchers at the Johns Hopkins University in Baltimore monitored nearly 5000 elderly residents of Cache County in Utah for about 8 years and analyzed their intake of vitamins C and E, and ibuprofen. They found that there were 127 people who regularly took all three drugs. These people exhibited less decline in their mental performance, lead researcher Dr. Majid Fotuhi said at the American Academy of Neurology's annual meeting. "With this approach, we've advanced a two-point attack on the cascade of events that leads to Alzheimer's disease pathology," he said. "On the one hand, we reduce inflammation (with vitamins E and C), and on the other hand, we reduce the amount of amyloid in the brain (with ibuprofen), the substrate that causes inflammation." APOE-4 carriers seemed to have the biggest benefit from the combination of all three drugs. And these patients, all in their 60s or 70s did not show any decline in their mental faculties in the 8-year follow-up study. "So if patients seem to be at high risk, such as having several family members with Alzheimer's disease or with early memory loss, they are likely to benefit the most from the triple-combination therapy," the researchers said. Fotuhi, however cautions against using too much ibuprofen since it is known to cause stomach ulcers. A dosage of 100 milligrams per day appears to be enough, he said.

Page: 1

Related medicine news :

1. Ibuprofen weakens aspirins effect
2. Ibuprofen to lower risk of Parkinson’s diseas
3. Safest painkiller Ibuprofen found to cause severe GI bleeding
4. Use Of Ibuprofen Safe For Short Periods
5. Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities
6. Children Find Effective Pain Relief With Ibuprofen
7. Ibuprofen Risky for Heart Patients?
8. Vitamins-The answer to Heart Disease?
9. Vitamins reduce pre-eclampsia
10. Vitamins enhances recuperation of organ transplant patients
11. Vitamins suppress artery injury after transplant
Post Your Comments:

(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology: